KALA BIO, INC. Inventory, Work in Process, Gross
KALA BIO, INC. (KALA) had Inventory, Work in Process, Gross of $9.74 million as of 2022-03-31, per its 10-Q filed 2022-05-16.
Discontinued › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryWorkInProcess · last filed 2023-03-03
- 2022-03-31: Inventory, Work in Process, Gross $9.74M.
- 2021-12-31: Inventory, Work in Process, Gross $9.80M.
- 2021-09-30: Inventory, Work in Process, Gross $11.89M.
- 2021-06-30: Inventory, Work in Process, Gross $9.58M.
| Period end | Inventory, Work in Process, Gross |
|---|---|
| 2022-03-31 | $9.74M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $9.80M 10-K · filed 2023-03-03 |
| 2021-09-30 | $11.89M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $9.58M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $9.30M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $6.44M 10-K · filed 2022-03-29 |
| 2020-09-30 | $4.98M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $4.59M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $3.54M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $4.17M 10-K · filed 2021-02-25 |
| 2019-09-30 | $5.19M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $6.93M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $4.25M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $3.36M 10-K · filed 2020-02-12 |
| 2018-09-30 | $976.00K 10-Q · filed 2018-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |